Breast Reconstruction Market - Developing Regions Is Well-positioned For Strong Growth In The Coming Years

By Author: robert henric
Total Articles: 492
Comment this article

Growth Factors Driving the Market: The emergence of 3D-printed implants can provide significant opportunities for market growth. German companies, BellaSeno and Evonik, have entered into a collaboration to develop 3D breast implant technology. BellaSeno will use Evonik’s Resomer bioresorbable polymer in its Senella breast scaffolds, avoiding the use of silicone implants that have raised major safety concerns.

BellaSeno planned to start the first human clinical trials of the Senella scaffolds with Resomer in Germany in 2019. Evonik has supplied its Resomer polymer for clinical and commercial use. The scaffolds are designed to guide the growth of the natural tissue using the patient's body fat harvested via liposuction. This product is designed to be used after augmentation, reconstruction, and revision surgery. This is progressively reabsorbed by the body and replaced with natural breast tissue. This technology avoids the use of silicone implants and their associated complications & risk, like capsular contracture, rupture, and deflation. Moreover, in December 2021, Bellaseno GmbH reported the publication of first-in-human ...
... data for its 3D-printed biodegradable and highly porous Senella scaffold filled with an autologous fat graft to correct a chest deformation in a 22-year-old patient with severe pectus excavatum. The article was published in the European Journal of Plastic Surgery.

MarketsandMarkets™ View on Revenue: The global breast reconstruction market size is expected to grow from USD 647 million by 2026 to USD 567 million in 2021, at a CAGR of 2.7%.

Industry Segmentation in Detailed:

"Breast implants accounted for the largest share of the breast reconstruction market"

Based on the product, the breast reconstruction market is segmented into breast implants, tissue expanders, and acellular dermal matrix. The breast implants segment accounted for the largest market share in 2020.

"The immediate procedures segment accounted for the largest market share in 2020."

Based on the procedure, the breast reconstruction market is segmented into immediate, delayed, and revision procedures. The immediate procedures segment accounted for the largest market share in 2020. This is primarily attributed to the increasing number of surgeries post-mastectomy and rising awareness.

"The unilateral segment accounted for the largest market share in 2020."

Based on type, the breast reconstruction market is segmented into unilateral and bilateral. The unilateral segment accounted for the largest market share in 2020. The increasing incidence of breast cancer and rising awareness are major factors responsible for the dominant share of this segment.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=186501593

Leading Key Players Analysis:

The prominent players operating in this market include Mentor Worldwide LLC (Johnson & Johnson) (US), are Allergan Aesthetics (an Abbvie company) (US), Ideal Implant Incorporated (US), Sebbin (France), GC Aesthetics (Ireland), POLYTECH Health & Aesthetics (Germany), Sientra (US), Integra Lifesciences (US), RTI Surgical Holdings (US), Establishment Labs S.A. (US), Silimed (Brazil), Laboratories Arion (France), and other players are Guangzhou Wanhe Plastic Materials Co. Ltd.(China), CEREPLAS (France), HansBiomed (South Korea), PMT Corporation (US), and Shanghai Kangning Medical Device (China)

Mentor Worldwide LLC (Johnson & Johnson) (US) is one of the leading players in the breast reconstruction market. The company offers a broad product portfolio across the globe. Over the years, the company has maintained its leading position in the breast reconstruction market.

Geographical Trends in Detailed:

North America was the largest regional market for breast reconstruction in 2020;

The breast reconstruction market is segmented into North America, Europe, the Asia Pacific, and the Rest of the World. In 2020, North America held the largest share of the market, followed by Europe. The rising incidences of breast cancer, increasing awareness of breast reconstruction, and FDA approvals for breast reconstruction products in this region are the major factors driving the growth of the breast reconstruction in North America.

Request Research Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=186501593